AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 181 min read$LIFE

Colis Peter George sold $2.7M of LIFE

Colis Peter George (CEO and Secretary) sold 70,000 shares of Ethos Technologies Inc. (LIFE) at an average of $38.51 ($35.98–$40.35, $2.70M total) across 8 trades over 2026-09-16 to 2026-09-18 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Colis Peter George
Published Sep 18, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 11:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$LIFE
Bearish
medium confidence
Mentioned
$LIFE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LIFEBearishLow
01

Why it matters

The disclosed sale represents a material cash outflow by the CEO, potentially influencing short‑term price dynamics.

02

Market read

Primary insider sale news; limited broader market impact but relevant for traders holding or shorting LIFE.

03

What to watch

CEO retains majority of shares (1.5M) and may have other undisclosed strategic reasons.

Relevance 5/10Novelty 7/10Timing: filed today

Background

Form 4 filing reports insider transactions required by SEC, providing transparent ownership changes.

Company-level read

Ticker impact

$LIFEBearishMedium confidence
Context

SEC Form 4 disclosed CEO sold $2.7M of shares via 10b5-1 plan.

Expected impact

Possible modest decline in near-term trading as market digests sell volume.

Evidence & confidence

Sale size is material for a micro‑cap, executed under a pre‑arranged plan, but no accompanying corporate news.

Market effects

Sector

Minimal; insider activity does not affect broader sector.

Regional

None; company is US‑listed with limited market footprint.

Global

Low; only relevant to investors in LIFE.

Counterpoint

What could challenge this read

Insider sell may be routine under 10b5‑1 and not indicative of future performance.

Key entities

  • Company
    Ethos Technologies Inc.

    Issuer of ticker LIFE, reporting the insider transaction.

  • Person
    Colis Peter George

    CEO and Secretary of Ethos Technologies, seller of shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

LIFE insider trading history →

Related articles

OCT 1
$LIFEMed

JPMorgan downgrades Ethos Technologies stock rating to neutral

JPMorgan downgraded Ethos Technologies (LIFE) to Neutral from Overweight, setting a $37 price target. The stock has surged 99% year-to-date. JPMorgan notes growth potential but cites balanced risk-reward and relative valuation concerns. Ethos reported Q2 2026 revenue of $189.6M, up 113% YoY, and raised full-year guidance to $727M-$731M. Other firms adjusted targets post-results.

investing.com2 min
SEP 3
$LIFEMed

Ethos (LIFE) Grows Revenue 113% While Margins Quietly Compress

Ethos Technologies (LIFE) reported Q2 revenue growth of 113% to $189.6M, with new policies up 133%. Gross profit margin was 98%, but net income rose only 5% to $19.5M. The company authorized a $100M stock buyback. Q3 revenue guidance is $160M-$164M, and full-year guidance is $727M-$731M. Margins compressed, with GAAP net loss of $146.9M for H1 2026 due to stock-based compensation.

insidermonkey.com3 min
AUG 11
$LIFEMedAI 9/10

Ethos (LIFE) Q2 2026 Earnings Call Transcript

Ethos Technologies (LIFE) reported Q2 2026 revenue of $189.6 million, up 113% Y/Y, with direct revenue $116.5 million (+131%) and third-party revenue $73.1 million (+90%). Adjusted EBITDA was $35.2 million (19% margin). Net income was $19.5 million. Full-year 2026 guidance: revenue $727-$731 million and adjusted EBITDA $119-$123 million. Up to $100 million Class A repurchase authorized.

fool.com7 min
AUG 5
$LIFEMed

Top SMid Cap Pick: Ethos Technologies Leads Citi’s Rankings

Citi analyst Ronald Josey named Ethos Technologies (LIFE) his top SMID-cap pick after the company’s Q2 results. Activated policies growth accelerated to 133% YoY, with 107,800 net activated policies. Revenue rose to $189.6M (+113% YoY). Ethos raised 2026 revenue guidance to $727M-$731M and adjusted EBITDA to $119M-$123M. Citi lifted its price target to $33 and kept Buy/High Risk.

investing.com4 min